![Jan-Anders Christer Mellberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Jan-Anders Christer Mellberg
Voorzitter bij Quantovir AB
Profiel
Jan-Anders Christer Mellberg is currently the Chairman at Quantovir AB.
He has previously held positions as Chairman at Oncopeptides AB, DiLab i Lund AB, and Visionar Preclinical AB.
He was also a Director at Noster System AB, AroCell AB, Beactica Therapeutics AB, and Sensidose AB.
In addition, he served as the Chief Financial Officer & Executive Vice President at Procordia AB and Pharmacia Biotech AB, and as the Principal at Pripps Ringnes.
He was also the Chief Financial Officer at Pharmacia LKB Biotechnology, Inc.
Actieve functies van Jan-Anders Christer Mellberg
Bedrijven | Functie | Begin |
---|---|---|
Quantovir AB
![]() Quantovir AB Miscellaneous Commercial ServicesCommercial Services Quantovir AB conducts research and development of methods for cancer diagnostics and related business. It develops technology for quantitative measurement of high-risk Human Papillomavirus (HPV) types using deoxyribonucleic acid (DNA)-based detection. It demonstrates that a molecular diagnostic test measuring the quantity, or viral load, of HPV DNA present in cervical specimens can be used to predict a woman's risk of developing cervical cancer. The company was founded by Ulf Gyllensten on February 28, 2001 and is headquartered in Uppsala, Sweden. | Voorzitter | - |
Eerdere bekende functies van Jan-Anders Christer Mellberg
Bedrijven | Functie | Einde |
---|---|---|
Visionar Preclinical AB
![]() Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | Voorzitter | 21-11-2011 |
Noster System AB
![]() Noster System AB Electronic Equipment/InstrumentsElectronic Technology Noster System AB developed and marketed respiratory analysis systems. It developed a diagnostic aid for analyzing the occurrence of heliobacter polyri in the stomach. The company was located in Stockholm, Sweden. | Directeur/Bestuurslid | 09-06-2006 |
Pharmacia Biotech AB | Financieel Directeur/CFO | - |
AROCELL AB | Directeur/Bestuurslid | - |
Beactica Therapeutics AB
![]() Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Directeur/Bestuurslid | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 3 |
---|---|
ONCOPEPTIDES AB | Health Technology |
AROCELL AB | Health Technology |
SENSIDOSE AB | Electronic Technology |
Bedrijven in privébezit | 9 |
---|---|
Procordia AB | Health Technology |
Pharmacia Biotech AB | Health Technology |
Pripps Ringnes
![]() Pripps Ringnes Food DistributorsDistribution Services Part of Carlsberg A/S, Pripps Ringnes is a Finnish company that provides beverages. The company is based in Bromma, Finland. Pripps Ringnes was acquired by Carlsberg A/S on May 01, 2000. | Distribution Services |
Noster System AB
![]() Noster System AB Electronic Equipment/InstrumentsElectronic Technology Noster System AB developed and marketed respiratory analysis systems. It developed a diagnostic aid for analyzing the occurrence of heliobacter polyri in the stomach. The company was located in Stockholm, Sweden. | Electronic Technology |
DiLab i Lund AB
![]() DiLab i Lund AB Electronic Equipment/InstrumentsElectronic Technology DiLab AB offers instruments for automated blood sampling. The company was founded by Hans Axel Hansson in 1983 and is headquartered in Jonkopings lan, Sweden. | Electronic Technology |
Pharmacia LKB Biotechnology, Inc. | |
Beactica Therapeutics AB
![]() Beactica Therapeutics AB Medical DistributorsDistribution Services Beactica Therapeutics AB operates as a drug discovery company, utilizing its proprietary methodologies to evaluate the interactions of molecules in order to generate novel therapeutics. The firm's services include fragment-based lead generation, kinetic and mechanistic characterization of inhibitors, extended rate analysis, competition analysis, and antibody interaction analysis. The company was founded by Per K?llblad and Ulla Helena Danielson in 2006 and is headquartered in Uppsala, Sweden. | Distribution Services |
Visionar Preclinical AB
![]() Visionar Preclinical AB Miscellaneous Commercial ServicesCommercial Services Visionar Preclinical AB is a CRO specialized on in vivo preclinical contract research and services. The company was founded year 2000 by individuals with extensive experience of preclinical research and development in international pharmaceutical companies. Its customers are small and mid-size companies who work with drugs, biopharmaceuticals, or medical devices. Quality and flexibility are key factors in their work. Its extensive experience makes it possible for them to find unconventional solutions to preclinical matters. It work closely with their Sponsors to develop strategies for cost effective evaluation of drug candidates and to perform necessary regulatory studies for phase I-II clinical trials. | Commercial Services |
Quantovir AB
![]() Quantovir AB Miscellaneous Commercial ServicesCommercial Services Quantovir AB conducts research and development of methods for cancer diagnostics and related business. It develops technology for quantitative measurement of high-risk Human Papillomavirus (HPV) types using deoxyribonucleic acid (DNA)-based detection. It demonstrates that a molecular diagnostic test measuring the quantity, or viral load, of HPV DNA present in cervical specimens can be used to predict a woman's risk of developing cervical cancer. The company was founded by Ulf Gyllensten on February 28, 2001 and is headquartered in Uppsala, Sweden. | Commercial Services |